Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
CSBR
CSBR
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CSBR News
Champions Oncology (CSBR) Earnings Transcript
Mar 13 2026
NASDAQ.COM
Champions Oncology Reports Record Services Revenue in Q3 2026
Mar 12 2026
seekingalpha
Champions Oncology Reports Q3 Earnings Results
Mar 12 2026
seekingalpha
BLACKSTONE REVEALS DEAL TO PURCHASE CHAMPIONS GROUP
Feb 17 2026
moomoo
Champions Oncology (CSBR) Earnings Transcript
Jan 07 2026
NASDAQ.COM
Key Stocks Reporting Earnings This Week: Micron, FuelCell, Carnival, and Others
Dec 15 2025
Benzinga
Transcript of Champions Oncology, Inc. (CSBR) Earnings Call for Q1 2026
Sep 15 2025
Newsfilter
Champions Oncology aims for continuous revenue increase and improved margins as radiopharmaceuticals and data platforms progress.
Sep 15 2025
SeekingAlpha
Champions Oncology Reports Non-GAAP EPS of $0.02, Exceeding Estimates by $0.03; Revenue of $14M Surpasses Expectations by $0.49M
Sep 15 2025
SeekingAlpha
4 Biotech Stocks Experiencing Decline: Momentum Scores Diminishing in the Last Week
Sep 03 2025
Benzinga
Champions Oncology's (NASDAQ:CSBR) investors will be pleased with their respectable 47% return over the last year
Apr 13 2025
Yahoo Finance
Champions Oncology price target raised to $12 from $8 at Craig-Hallum
Mar 12 2025
Business Insider
CHAMPIONS ONCOLOGY Earnings Preview: Recent $CSBR Insider Trading, Hedge Fund Activity, and More
Mar 04 2025
NASDAQ.COM
Champions Oncology, Inc. (CSBR) Q2 2025 Earnings Call Transcript
Dec 11 2024
Newsfilter
Stocks Rise Before the Open as Investors Await Key U.S. PPI Data, ECB Decision in Focus
Sep 12 2024
NASDAQ.COM
Craig-Hallum Upgrades Champions Oncology to Buy, Maintains Price Target to $6
Sep 12 2024
Benzinga
Show More News
